Nant Capital, LLC

10% OwnerPanbela Therapeutics, Inc. (PBLA) · full profile →Form 4 · filed Nov 19, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 15, 2024Buy(P)0$9150000.00$0

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-128924) within minutes of acceptance. Every field above traces to the original document. Verify it directly: